Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease

NCT00584025 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study withdrawn due to personnel limitations.

Conditions

Parkinson's Disease

Interventions

DRUG: levetiracetam
DRUG: Placebo

Sponsor

University of South Florida